(4 years, 4 months ago)
Commons ChamberYes, our overseas network is working actively around the globe, particularly through our world-leading science and innovation network. The Vaccine Taskforce is also ensuring that work being done to find a vaccine in the UK complements and supports global efforts, including by providing industry and research institutions with resources and support. We welcome the announcement on 4 June of the innovative collaborations between AstraZeneca, CEPI, Gavi and the Serum Institute of India to support the production of 1.3 billion doses for global access to a potential covid-19 vaccine.
Israel is at the forefront of MedTech innovation, which presents many opportunities for the UK’s healthcare system, such as the use of AI technology in diagnostics and screening. Can my hon. Friend tell me what the Government’s plans are to strengthen partnerships between Israeli MedTech companies and UK researchers, particularly in the north-west, to help them not only develop a vaccine but better prepare for the potentiality of any future pandemic?
International collaboration is absolutely vital as we search for a vaccine, and finding a vaccine for covid-19 is a top priority for the Government. The Prime Minister has made it clear that we see vaccines as a global challenge and that no one country can do this alone. That is why the UK has called for clear global commitments from international partners to tackle the pandemic, including through the G7, the G20 and other international forums. The Prime Minister hosted a global vaccine summit on 4 June, which brought together more than 60 countries, including 44 Heads of State and Government, and raised an incredible $8.8 billion to support immunisation of more than 300 million children against vaccine preventable diseases.